Combination Oral Prednisone and Intravenous Immunoglobulin in the Treatment of Scleromyxedema
Why this work is in the frame
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Bibliographic record
Abstract
Scleromyxedema is a clinical variant of the rare disease papular mucinosis that has both cutaneous and systemic manifestations. Treatment options are numerous and tend to be associated with serious potential side effects and frequent relapse. We report a case of scleromyxedema treated with low-dose oral prednisone and intravenous immunoglobulin (IVIg). This is followed by a review of the literature. IVIg is being used for a growing number of inflammatory and immune disorders. It is being increasingly reported as a successful treatment for scleromyxedema. Although our patient succumbed to the disease, combination therapy with prednisone and IVIg provided temporary symptomatic, laboratory, and clinical improvement of the condition. Optimization of this therapeutic strategy is thus indicated for the management of scleromyxedema. Le scléromyxoedème est une variante clinique de la maladie rare mucinose papuleuse dont les manifestations sont à la fois cutanées et systémiques. Les options de traitement sont nombreuses et souvent associées é des effets secondaires graves et à des récidives fréquentes. Nous rapportons un cas de scléromyxoedème traité avec de faibles doses de prednisone oral et d’immunoglobuline intraveineuse. Par la suite, nous passons en revue les publications scientifiques. L’immunoglobuline intraveineuse est utilisée dans le traitement d’un. nombre de plus en plus élevé de maladies inflammatoires et auto-immunes. Les rapports sont de plus en plus fréquents sur son efficacité dans les cas de scléromyxoedème. Bien que patiente n’ait pas survécu à sa maladie, la polythérapie au prednisone et àl’immunoglobuline intraveineuse a permis une amélioration temporaire au niveau des symptômes ainsi que des résultats cliniques et de laboratoire. Ainsi, l’optimisation de cette thérapie est recommandée dans la gestion du scléromyxoedème.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.003 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it